Johnson and Johnson Continued To Push Risperdal To Elderly Despite FDA Warnings

All the way back in 1999 the FDA told Johnson and Johnson that their marketing material for Risperdal, an antipsychotic, was incorrect. The marketing materials overstated the benefits and minimized…

More in Health >